BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Ngui SL, Hallet R, Teo CG. Natural and iatrogenic variation in hepatitis B virus. Rev.Med.Virol. 1999;183­209.
Nguyen­Van­Tam J, Granfield R, Pearson J, Fleming D, Keating N. Do influenza epidemics affect patterns of sickness absence among British hospital staff?
Infect.Control Hosp.Epidemiol. 1999;691­4.
Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic
lung disease. Arch.Intern.Med. 1999;2437­42.
Nichol KL. Influenza vaccination for healthy working adults. Minn.Med. 1999;24­6.
Nicoara C, Zach K, Trachsel D, Germann D, Matter L. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.
Clin.Diagn.Lab Immunol. 1999;868­71.
Northrop­Clewes CA, Ahmad N, Paracha PI, Thurnham DI. Impact of health service provision on mothers and infants in a rural village in North West Frontier
Province, Pakistan. Public Health Nutr. 1998;51­9.
O'Dowd A. A shot in the dark. Nurs.Times 1999;16­7.
Oettinger T, Jorgensen M, Ladefoged A, Haslov K, Andersen P. Development of the Mycobacterium bovis BCG vaccine: review of the historical and
biochemical evidence for a genealogical tree. Tuber.Lung Dis. 1999;243­50.
Oggioni MR, Medaglini D, Maggi T, Pozzi G. Engineering the gram­positive cell surface for construction of bacterial vaccine vectors. Methods 1999;163­73.
Ogun TC, Uzumcu AU, Arazi M, Kapicioglu MI. Accidental Salmonella enteritidis vaccine injection leading to finger necrosis­­a report of 4 cases. Acta
Orthop.Scand. 1999;629­31.
Oh, J. KePRO priming for adult vaccination campaign Pa Med. 1999, 102 (11): 6.
Olin P. Vaccination programmes out of pace with vaccine development: a call for national vaccination registers. Acta Paediatr. 1999;800­2.
Omer MI. Measles: a disease that has to be eradicated. Ann.Trop.Paediatr. 1999;125­34.
O'Neill T, Kydd JH, Allen GP, Wattrang E, Mumford JA, Hannant D. Determination of equid herpesvirus 1­specific, CD8+, cytotoxic T lymphocyte precursor
frequencies in ponies. Vet.Immunol.Immunopathol. 1999;43­54.
Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination. Clin.Infect.Dis. 1999;S147­S150.
O'Shea S, Dunn H, Palmer S, Banatvala JE, Best JM. Automated rubella antibody screening:a cautionary tale [letter]. J.Med.Microbiol. 1999;1047.
O'Toole T. Smallpox: An attack scenario. Emerg.Infect.Dis. 1999;540­6.
Ozaki T, Morishima T, Hirota T, Sugiyama K, Asano Y. Pediatric admission for vaccine preventable diseases: a 5­year survey from 1994 to 1998 in Aichi
Prefecture. Jpn.J.Infect.Dis. 1999;208­13.
Palombo EA. Genetic and antigenic diversity of human rotaviruses: potential impact on the success of candidate vaccines. FEMS Microbiol.Lett. 1999;1­8.
Pang T. Vaccination in the Third World. Contemporary issues. C.R.Acad.Sci.III 1999;995­7.
Papania M, Baughman AL, Lee S, Cheek JE, Atkinson W, Redd SC, Spitalny K, Finelli L, Markowitz L. Increased susceptibility to measles in infants in the
United States. Pediatrics 1999;e59.
Pardigon N, Laouini D. New millenium. The need for new vaccines. C.R.Acad.Sci.III 1999;913­7.
Parenti D. Lyme disease vaccine­­LYMErix [letter]. Conn.Med. 1999;570.
Parkman PD. Making vaccination policy: the experience with rubella. Clin.Infect.Dis. 1999;S140­S146.
Pass RF, Duliege AM, Boppana S, Sekulovich R, Percell S, Britt W, Burke RL. A subunit cytomegalovirus vaccine based on recombinant envelope
glycoprotein B and a new adjuvant. J.Infect.Dis. 1999;970­5.
Passwell JH. MMR vaccination, Crohn's disease and autism: a real or imagined "stomach ache/ headache?" [editorial; comment]. Isr Med Assoc J 1999;
1(3):176­177.
Pebody RG, Ruutu P, Nohynek H, Leinikki P. Changing epidemiology of hepatitis B infection in Finland. Scand.J.Infect.Dis. 1999;251­4.
Peetermans WE, Lacante P. Pneumococcal vaccination by general practitioners: an evaluation of current practice. Vaccine 1999;612­7.
Peleman RA, Peetermans WE, Van Laethem Y, Bachez PG, Vanatoru J, Van Wassenhove K, Struelens MJ, Verhaegen JL. Prevention of pneumococcal
disease: an update on the Belgian Consensus Report. Acta Clin.Belg. 1999;321­7.
Pelton SI, Klein JO. The promise of immunoprophylaxis for prevention of acute otitis media. Pediatr.Infect.Dis.J. 1999;926­35.
Pennie RA. Pneumococcal vaccine [editorial; comment]. Can.Fam.Physician 1999;2271­7.
Perez­Cuevas R, Reyes H, Pego U, Tome P, Ceja K, Flores S, Gutierrez G. Immunization promotion activities: are they effective in encouraging mothers to
immunize their children? Soc.Sci.Med. 1999;921­32.
Peters S. Into the woods. New weapons against Lyme disease. Adv Nurse Pract 1999 Oct;7(10):53­4, 82.
Peterson EM, You JZ, Motin V, de la Maza LM. Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal
challenge with the homologous serovar. Vaccine 1999;2901­7.
Petousis­Harris H, Turner N. Hepatitis B vaccination and diabetes. N Z Med J. 1999 Aug 13;112(1093):303­4.
Pichichero ME, Voloshen T, Zajac D, Passador S. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheriatetanus­acellular
pertussis­hib­hepatitis B combined vaccine in infants. J.Infect.Dis. 1999;1390­3.
Pieters R, Albers R. Screening tests for autoimmune­related immunotoxicity. Environ Health Perspect 1999 Oct;107 Suppl 5:673­7.
Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a
12­year experience. Vaccine 1999;181­9.
Plotkin SA. Vaccination against the major infectious diseases. C.R.Acad.Sci.III 1999;943­51.
Poltera AA. Aluminium chelation in chronic haemodialysis and aluminium adjuvanted vaccines [letter]. Vaccine 1999;577­8.
Pramoolsinsap C, Poovorawan Y, Hirsch P, Busagorn N, Attamasirikul K. Acute, hepatitis­A super­infection in HBV carriers, or chronic liver disease related
to HBV or HCV. Ann Trop Med Parasitol 1999; 93(7):745­751.
Press R, Solders G. A case report. A vaccine against tick­borne encephalitis caused polyneuritis. Lakartidningen. 1999 Jul 28;96(30­31):3341­2.
Prober CG, Sullender WM. Advances in prevention of respiratory syncytial virus infections. J.Pediatr. 1999;546­58.
Puolakkainen M, Makela PH. Vaccination against infections by Chlamydia pneumoniae. C.R.Acad.Sci.III 1999;973­8.
Rabaud C, Barbaud A, Trechot P. First case of erythermalgia related to hepatitis B vaccination. J Rheumatol. 1999 Jan;26(1):233­4.
Rabbani F, Merchant AT. Economic development and health status among the poor in squatter settlements of Karachi. JPMA J.Pak.Med.Assoc. 1999;117­21.
Rabinovich NR, Orenstein WA. Vaccines. Overview. Epidemiol.Rev. 1999;1­6.
Rahman MM, Gu XX, Tsai CM, Kolli VS, Carlson W. The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non­typeable
Haemophilus influenzae strain NTHi 9274. Glycobiology 1999;1371­80.
Rao MN, Joshi N, Habibullah CM. Immunogenicity of a low dose of indigenously developed recombinant hepatitis­B vaccine in neonates and infants. Indian
Pediatr 1999 Jun;36(6):581­3.
Ravenscroft N, Averani G, Bartoloni A, Berti S, Bigio M, Carinci V, Costantino P, D'Ascenzi S, Giannozzi A, Norelli F, Pennatini C, Proietti D, Ceccarini C,
Cescutti P. Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines. Vaccine 1999;2802­16.
Reflecting the extraordinary pace of change. Canadian Immunization Guide. Laboratory Centre for Disease Control, Health Protection Branch, Health Canada.
Can Fam Physician 1999 Jan;45:135­8.
Rehermann B. Cellular immune response to the hepatitis C virus. J Viral Hepat 1999; 6 Suppl 1:31­35.
Reid G. Potential preventive strategies and therapies in urinary tract infection. World J.Urol. 1999;359­63.
Renard JL, Guillamo JS, Ramirez JM, Taillia H, Felten D, Buisson Y. Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti­
HBs antibodies. Presse Med 1999 Jul 3­10;28(24):1290­2.